Ahmed A. Noser

Synthesis, In Silico and In Vitro Assessment of New Quinazolinones as Anticancer Agents via Potential AKT Inhibition

Ahmed A. Noser, Mohamed El-Naggar, Thoria Donia et al. · Molecules · 2020 · 50 citations · Full text

Newly Synthesized Pyrazolinone Chalcones as Anticancer Agents via Inhibiting the PI3K/Akt/ERK1/2 Signaling Pathway

Ahmed A. Noser, Ihsan A. Shehadi, Aboubakr H. Abdelmonsef et al. · ACS Omega · 2022 · 43 citations · Full text

New Amino Acid Schiff Bases as Anticancer Agents via Potential Mitochondrial Complex I-Associated Hexokinase Inhibition and Targeting AMP-Protein Kinases/mTOR Signaling Pathway

Ahmed A. Noser, Aboubakr H. Abdelmonsef, Mohamed El‐Naggar et al. · Molecules · 2021 · 37 citations · Full text

Design, synthesis and molecular docking of novel substituted azepines as inhibitors of PI3K/Akt/TSC2/mTOR signaling pathway in colorectal carcinoma

Ahmed A. Noser, Aboubakr H. Abdelmonsef, Maha M. Salem · Bioorganic Chemistry · 2022 · 34 citations

Medicinal Chemistry, Oncology, Medicine +9

Design, synthesis, in-silico and biological evaluation of novel 2-Amino-1,3,4-thiadiazole based hydrides as B-cell lymphoma-2 inhibitors with potential anticancer effects

Seham A. Ibrahim, Maha M. Salem, Hayam A. Abd Elsalam et al. · Journal of Molecular Structure · 2022 · 27 citations

Medicinal Chemistry, Biochemistry, B-cell Lymphoma-2 Inhibitors +10